About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic

NCT01279265·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

The University of Texas Health Science Center, Houston

With

Mead Johnson Nutrition

Age

0–0

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Sixty healthy full-term colicky infants (gestational age 32 wks to 41 wks)

You may not be if

chronic lung disease,
diarrhea (stools that take the shape of a container \> 5x daily)
fever

The record

StatusCompleted

PhaseNo phase

Taking part30

StartedSep 2011

UpdatedNov 11, 2015

Conditions

Colic Inflammation

Where1

University of Texas Health Science Center at Houston
Houston, Texas, United States

Clareo Health | Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic